A detailed history of Tokio Marine Asset Management CO LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 10,579 shares of FOLD stock, worth $104,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,579
Holding current value
$104,626
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$9.55 - $12.09 $101,029 - $127,900
10,579 New
10,579 $112,000
Q1 2017

Jan 11, 2018

BUY
N/A
55,900
55,900 $399,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.